These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 15118640

  • 1. Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause.
    Brownley KA, Hinderliter AL, West SG, Grewen KM, Steege JF, Girdler SS, Light KC.
    Am J Obstet Gynecol; 2004 Apr; 190(4):1052-8. PubMed ID: 15118640
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 3. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 4. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S, Jirapinyo M, Chaovisitsaree S, Wipatavit V, Bunyaviroch S, Kanluan B, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N.
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
    Taskin O, Muderrisoglu H, Akar M, Simsek M, Mendilcioglu I, Kursun S.
    Maturitas; 2004 Aug 20; 48(4):354-9. PubMed ID: 15283927
    [Abstract] [Full Text] [Related]

  • 9. Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes.
    Huston SA, Kirking DM, Shimp LA.
    Maturitas; 2006 Aug 20; 55(1):58-68. PubMed ID: 16504429
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP.
    Pacing Clin Electrophysiol; 2005 Jan 20; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [Abstract] [Full Text] [Related]

  • 11. Influence of estrogen replacement therapy on cardiovascular responses to stress of healthy postmenopausal women.
    Matthews KA, Flory JD, Owens JF, Harris KF, Berga SL.
    Psychophysiology; 2001 May 20; 38(3):391-8. PubMed ID: 11352127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
    de Paula FJ, Soares JM, Haidar MA, de Lima GR, Baracat EC.
    Maturitas; 2007 Jan 20; 56(1):69-77. PubMed ID: 16822626
    [Abstract] [Full Text] [Related]

  • 14. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A, Gambacciani M, Vitale C, Monteleone P, Ciaponi M, Fini M, Genazzani AR, Mercuro G, Rosano GM.
    Maturitas; 2005 Apr 11; 50(4):305-11. PubMed ID: 15780531
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM.
    Maturitas; 2005 Apr 11; 50(4):239-46. PubMed ID: 15780522
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM.
    Bone; 2007 May 11; 40(5):1244-51. PubMed ID: 17291843
    [Abstract] [Full Text] [Related]

  • 19. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.
    Maturitas; 2005 Feb 14; 50(2):91-7. PubMed ID: 15653005
    [Abstract] [Full Text] [Related]

  • 20. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
    Pirimoglu ZM, Aygun E, Dansuk R, Kucukercan I, Unal O, Turan C.
    Gynecol Endocrinol; 2005 Sep 14; 21(3):185-8. PubMed ID: 16335913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.